Is It Safe to Buy Test Subjects? | GenomeWeb

According to a recent study out of Johns Hopkins, clinical trials that pay participants attract mostly poor volunteers who join repeatedly, and may enroll in multiple trials at the same time. While there is no substitute yet for human trials, the long-term health effects of repeatedly volunteering remain murky, and it could also be risky for scientific clinical validation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.